Results 201 to 210 of about 241,963 (315)

SLE Accompanied by Antecedent or Striking Psychoneurological Symptoms

, 1981
Susumu Ôkubo, Hiroshi Okubo, Yohei Kashii, Yukiyoshi Yamamoto, Shigekazu Okamoto, Makoto Oda, Fumihiko Uba   +6 more
openalex   +2 more sources

OP0019 Baricitinib in systemic lupus erythematosus (SLE): results from a phase 2, randomised, double-blind, placebo-controlled study [PDF]

, 2018
Daniel J. Wallace, Richard Furie, Yoshiya Tanaka, Kenneth Kalunian, Marta Mosca, Michelle Petri, Thomas Dörner, Mario H. Cardiel, Ian N Bruce, E. Gómez, Tara Carmack, Jonathan Janes, Matthew D. Linnik, M. Silk, Robert W. Hoffman   +14 more
openalex   +1 more source

Atopic Comorbidities Associated With Chronic Spontaneous Urticaria: A Case‐Control Analysis of the All of Us Research Program

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Chronic spontaneous urticaria (CSU) is a mast cell‐driven condition defined by recurrent wheals and/or angioedema lasting over 6 weeks without an identifiable trigger. Though CSU is known to co‐occur with atopic diseases and share Th2‐dominant immunologic pathways, prior studies have not adequately addressed these relationships in ...
Julian A. Cortes, Nana Ama Adjei‐Frimpong, Savannah K. Fakhouri, Francesco Delacqua, Reid Oldenburg   +4 more
wiley   +1 more source

A study of clinical manifestations and associated factors in photosensitive patients with systemic lupus erythematosus. [PDF]

Eur J Med Res
He JH, Song ZQ, Hui-Li, Kang YJ.
europepmc   +1 more source

Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a chronic autoimmune hair loss disorder. Patients with primary autoimmune diseases commonly use systemic immunomodulators to manage disease and have an increased risk of developing AA. Systemic immunomodulators have diverse immunologic effects, but their impact on AA risk is not well understood. Objectives We
Angela Rose Liu, Nada Hentati, Bethany R. Rohr   +2 more
wiley   +1 more source

Systemic Treatment Strategies for Patients with Psoriasis and Psoriatic Arthritis in the Setting of ANA Positivity or Lupus Spectrum Disease: A Comprehensive Systematic Review. [PDF]

Int J Mol Sci
Tjiu JW, Tsai TF.
europepmc   +1 more source

Risk factors for systemic lupus erythematosus complicated with tuberculosis infection: meta-analyses and systematic reviews. [PDF]

PeerJ
Zhang X, Zheng H, Zhou P, Hu W, Si Y, Wu X, Shen C.   +6 more
europepmc   +1 more source

Present state of SLE treatments. Treatment methods taking into consideration of generation mechanism of B cell abnormal activity.

, 1989
上田 裕司, 坂根 剛, 恒松 徳五郎   +2 more
openalex   +2 more sources

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Telitacicept versus belimumab for the treatment of systemic lupus erythematosus: a network meta-analysis and cost-effectiveness analysis. [PDF]

Lupus Sci Med
Deng L, Wang H, Yuan D, Tan C, Peng Y, Yi L, Wen Z.   +6 more
europepmc   +1 more source